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The response to a DNAdouble-stranded break inmammalian cells is a process
of sensing and signalling the lesion. It results in halting the cell cycle and
local transcription and in the mediation of the DNA repair process itself.
The response is launched through a series of post-translational modification
signalling events coordinated by phosphorylation and ubiquitination. More
recently modifications of proteins by Small Ubiquitin-like MOdifier (SUMO)
isoforms have also been found to be key to coordination of the response
(Morris et al. 2009 Nature 462, 886–890 (doi:10.1038/nature08593); Galanty
et al. 2009 Nature 462, 935–939 (doi:10.1038/nature08657)). However our
understanding of the role of SUMOylation is slight compared with our
growing knowledge of how ubiquitin drives signal amplification and key
chromatin interactions. In this review we consider our current knowledge of
how SUMO isoforms, SUMO conjugation machinery, SUMO proteases and
SUMO-interacting proteins contribute to directing altered chromatin states
and to repair-protein kinetics at a double-stranded DNA lesion in mammalian
cells. We also consider the gaps in our understanding.
This article is part of the themed issue ‘Chromatin modifiers and
remodellers in DNA repair and signalling’.1. Overview of the SUMO system
The Small Ubiquitin-like MOdifier (SUMO) system has relatively few enzymatic
components, but unlike the ubiquitin system, there are several modifier isoforms
(in mammals: SUMO1–5). SUMO proteins are approximately 12 kDa in size and
have similarities to the three-dimensional structure of ubiquitin; however they
share less than 20% amino acid identity and carry a different surface charge dis-
tribution [1]. Mature SUMO2 and SUMO3 are near identical (referred to as
SUMO2/3) and share 50% identity with SUMO1. All SUMO proteins are
expressed as an immature pro-form which must be cleaved prior to conjugation
(figure 1). Whether SUMO4 is processed to a mature form [5–7] and whether
the recently described SUMO5 is expressed [8] or a pseudogene [9] remains con-
troversial. SUMO isoforms are conjugated to targets through three enzymatic
steps: activation, involving the heterodimer E1 enzyme (SAE1 þ SAE2); conju-
gation, involving the E2 enzyme (UBE2I/UBC9); and substrate modification,
through the cooperation of the E2 with E3 protein ligases (figure 1). PIAS type
SUMO E3 enzymes, which possess an SP-RING motif similar to the RING
domain of many E3 ubiquitin ligases, are the best understood members.
SUMOylation is most frequent at a lysine within cKxE/D-type motifs
(figure 2) (where c represents a small hydrophobic amino acid and x any
amino acid) which are directly recognized by the SUMO E2 UBC9 [12]. SUMO-
ylation can be in the form of conjugation of a single SUMO to an acceptor
lysine, or as in the ubiquitin system in the form of chains as polySUMO. These
chains are generated on SUMO2/3 which, unlike SUMO1, possesses a cKxE-
typemotif. SUMOylation can be affected by local environment;many SUMOcon-
sensus sites are embeddedwithin patches of negatively charged amino acids [13].
Additionally, alterations in local charge, induced by phosphorylation of Ser/Thr
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Figure 1. The SUMO cycle. SUMO1/2/3 isoforms are processed from their immature ( pro)-forms into mature SUMO exposing the C-terminal GG motif. SENP1 is
proposed to be the dominant SUMO maturing protease, although other SENPs have this ability in vitro [2]. Heterodimeric SUMO E1 enzyme adenylates the
C-terminal diglycine followed by thioester formation with a Cys residue within the SAE2 subunit of the SUMO E1. The thioester is then transferred to a Cys residue
within the E2 enzyme UBC9. SUMO can be conjugated directly to a Lys residue or residues on target proteins through the E2, or with the aid of SUMO E3 ligase. The
E3 improves conjugation by either recruiting E2SUMO to a substrate or enhancing SUMO discharge from the E2 to the substrate. It is not yet clear if SUMO
polymers are formed sequentially or if specialized E3 elongases (E4 enzymes) such as ZNF451 extend existing SUMO monomers [3,4]. SUMO polymers recruit
multi-SIM-containing ubiquitin E3 ligases such as RNF4 and RNF111 to promote ubiquitination of the SUMO. This ubiquitinated SUMO can target the substrate
for proteasome degradation. At least two de-ubiquitinating proteins, USP11 and USP7, are able to remove ubiquitin from SUMO polymers. SUMO polymers are
disassembled via SENP6 and SENP7, while monomeric SUMO is deconjugated by SENPs1/2/3/5. Free SUMO released from substrates is then available to feed
back into the conjugation cycle.
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Figure 2. SUMO and SIM consensus (adapted from [10]). SUMO conjugation
sites (left) are often found within the consensus cKxE/D where c is a hydro-
phobic amino acid and x is any amino acid. Several variants including an
inverted variant, and variants with additional acidic patches of amino acids
or phosphorylated Ser/Thr residues have been identified. Approximately
25% of SUMO sites do not conform to any consensus [11]. Hydrophobic
SUMO Interacting Motifs (SIMs) (right).
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[14–16]. Under stress conditions SUMOylation frequently
occurs at non-consensus lysines on target proteins [11].
In contrast to the array of proteases in the ubiquitin system
just nine proteins have been identified with ability to process
SUMO conjugates. In mammalian cells the two main classes
of sentrin (SUMO)-specific proteases are related to the
yeast Ulp1 (SENP1-3 and SENP5) and Ulp2 (SENP6 and 7)
SUMO proteases. These enzymes differ in their maturation
(C-terminal hydrolase) versus isopeptide cleavage activity
and also in their preferences for different SUMO paralogues.Divergent amino termini of SENP proteins also result in
differing sub-cellular localizations thereby restricting substrate
access (reviewed in [2]). In addition a further class of proteases,
named DeSI-1/2 (DeSUMOylated Isopeptidase 1/2) [17],
with isopeptidase but little maturation capacity [18], and the
previously assigned ubiquitin-specific protease (USPL1),
which locates to Cajal bodies, have been revealed as SUMO
isopeptidases [19]. Dramatic increases in SUMOylation profiles
are reproducibly observed when SENP enzymes are blocked.
For example, large increases in protein SUMOylation are
observed in cells expressing mutants of SUMO that are resist-
ant to SENP interaction [20], while heat shock inactivates
SENP catalytic domains [21] and results in global increases
in protein SUMOylation [22]. Thus SUMO proteases seem
constitutively active under resting conditions and SUMO
homeostasis appears to favour deSUMOylation.
SUMO can act as a docking signal promoting protein–
protein interactions (reviewed in [23]). Various iterations of
short hydrophobic patches known as SIMs (SUMO-Interacting
Motifs) have been identified with a common consensus of
[c]-[c]-[x]-[c] where c most commonly represents isoleucine,
leucine or valine [10,24–26] (figure 2). This peptide interacts
with a groove on SUMO isoforms formed between the b2
strand and the first a-helix (reviewed in [27]). Two additional
domains have been shown to interact with SUMO. The MYM
class of zinc finger found in ZMYM3 and ZMYM2 interacts
with the same surface patch on SUMO as SIM motifs [28].
The MYM fingers of ZMYM2 are important for interaction
with HDAC1 within the LDS1/Co/REST/HDAC1 complex
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[29,30]. Secondly the ZZ domain, found in HERC2 and acetyl-
transferase CBP, has also been shown to interact with SUMO1,
but using a different surface from SIM motifs [31,32]. Thus
multiple domains could interact with single SUMO moieties.
It seems likely that additional SUMO binding domains
remain to be identified.
Finally molecular mimicry of SUMO in the structurally
related SUMO-like domains (SLDs) has the ability to disrupt
and co-opt aspects of the SUMO conjugation system. The
yeast RAD60 carries three SLD domains each able to interact
with different proteins in the SUMO-conjugation machinery
[33]. RAD60-SLD2, although bearing surface charge different
from SUMO has a similar face for interaction with the SUMO
E2 and through this face may direct SUMOylation [33]. Simi-
larly mouse Nip45 SLD2 interacts with UBC9 and inhibits the
elongation of poly-SUMO chains [34]. The SLDs of UAF1, a
partner protein to many de-ubiquitinating enzymes, is suffi-
ciently similar to SUMO to interact with the SIMs in
RAD51AP1 and in FANCI [35,36].
2. The fate of SUMOylated proteins
The catalogue of the mammalian cellular SUMO proteome,
including targets in the DNA damage response (DDR), has
expanded in recent years thanks to the efforts of several
researchers using improved mass-spectrometry approaches
to overcome the difficulties of mapping endogenous SUMO
conjugation sites [16,22,37–44]. However for most individual
proteins whether the modification has a functional role and
what that role might be are not known. SUMO conjugation
can block other PTMs at particular lysines, for example
p53-K386 SUMOylation blocks its acetylation and subsequent
DNA binding [45]. More often in targeted mutation exper-
iments SUMO conjugation sites are found to be redundant
and loss of a single SUMOylation site, with some exceptions
(e.g. RanGAP [46], Sp3 [47], yeast PCNA (reviewed in [48])),
has little impact on target-protein SUMOylation or target-
protein function [26]. Nevertheless, SUMOylation can impact
the function of a target protein through directing intra- or
inter-molecular contacts via SIMs. Where SIM and SUMOyla-
tion site are found within a protein, SUMOylation can alter
protein conformation. The most prominent example of this is
thymine-DNA glycosylase, which recognizes mismatches in
the process of base excision repair. SUMO conjugated at a
single C-terminal lysine interacts with the nearby SIM
promoting formation of a protruded a-helixwithin the catalytic
domain, which is associated with reduced DNA binding
[49–52].
When SUMOylation is restricted to a local area, such as at a
DNA double-strand break (DSB), the SUMOylation ‘spray’ can
promote protein group modification. This was first described
in the yeast DDR, in which a SUMO conjugation wave brought
about by the interaction of the E3 SUMO ligase Siz2 with DNA
andMre11 results inmodification of protein groups promoting
SUMO-SIM interactions between members of those groups
[26,53]. Similarly in mammalian cells treatment with the
alkylating agent methyl methanesulfonate (MMS) results in a
network of SUMOylated proteins centred on PARP1 and his-
tone acetyl transferase P300/CBP [11,41]. The ligase(s) that
‘spray’ this network are not yet identified.
Alternatively the interaction between SUMO-conjugated
target and SIMs of a partner can result in the degradation ofthe target protein through the activity of SUMO targeting Ub
(ubiquitin) ligases (STUbls), such as Arkadia/RNF111 or
RNF4 (orthologue of S. pombeRfp1 andRfp2 and Saccharomyces
cerevisiae Slx5/8 proteins) [54–56]. This class of protein inter-
acts with the SUMO-modified proteins through tandem SIM
motifs and directs the modification of the protein or the conju-
gated SUMO. STUbls [57,58], and possibly other ligases [59],
may generate hybrid SUMO-Ub chains, indeed Ub is a signifi-
cant target of SUMOylation [41]. Intriguingly the STUbl RNF4
is predominately monomeric and inactive in cells, but is acti-
vated by the presence of SUMO chains. On binding its
tandem SIMs, SUMO chains promote RNF4 dimerization
and ligase activity [60]. Thus RNF4 may ‘read’ highly SUMO-
ylated proteins.
Functionally RNF4-mediated ubiquitination is often
coupled to VCP/p97 (CDC48) activity. VCP is a multimeric
ATPase that, with cofactors, is able to extract ubiquitinated pro-
teins from membranes and protein complexes and direct them
for proteasomal-mediated degradation (reviewed in relation to
DSBs in this issue by Kristijan Ramadan and co-workers [61]).
Deubiquitinating enzymes with the ability to remove Ub from
SUMO-Ub chains include USP11 [57] and USP7 [62] although
the degree to which these enzymes have a particular specificity
for Ub conjugated to SUMO, rather than to another substrate, is
not yet clear. In yeast a cofactor of the VCP homologue CDC48
called Ufd1 also binds SUMO [63]. This protein contributes to
the displacement of SUMOylated proteins from DNA and in
particular acts to restrain Rad51/Rad52 interactions [64]. Ufd1
is conserved in mammalian cells, and may perform a similar
role [64], so that it is possible SUMOylation directs protein
extraction without the need for a Ub conjugate intermediate.
While target-protein interaction with, and activity
of, SUMO ligases versus SUMO proteases determine a pro-
tein’s SUMO conjugation status, what then defines the fate
of a SUMO modification is not yet obvious. Since the
mediators of these fates chiefly interact with the same
groove on SUMO isoforms, SIM-containing partners are
likely to compete for SUMO on the modified protein, predict-
ing that local partner proximity and relative concentrations
are likely to regulate outcome. In addition some interactions
may be a matter of degree, where high levels of
mono-SUMOylation or polySUMOylation, not met with a
competing, and ‘protective’, SIM, may favour interaction
with STUbls resulting in protein extraction and loss (pro-
posed model in figure 3)3. The SUMO system in the DNA damage
response
Atmicro-laser lines of DNA damage, prominent UBC9, PIAS1
and PIAS4 SUMO E3 ligase recruitment is observed together
with weak SUMO E1 (SAE1) accumulation [65]. Moreover,
SUMO1 and SUMO2/3 are detected in irradiation
(IR)-induced foci (IRIF), laser-induced damage, and Lac
arrays harbouring DSBs, and can be precipitated from
damaged chromatin [65–70]. SUMO recruitment at damaged
sites is dependent on the SUMO E3 ligases PIAS1/4 and on
their DNA binding SAP domains [65]. In a parallel pathway
the polycomb repressor complex 1 (PRC1) component and
SUMO E3 ligase CBX4 are recruited through poly(ADP-
ribose) polymerase (PARP) activity to sites of DNA damage
[70]. Cells depleted for PIAS1 or PIAS4 have defects in the
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Figure 3. Proposed model of how SUMO conjugation and SIM-bearing
proteins direct functional outcome for modified targets. The degree of
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tion (HR) and non-homologous end-joining (NHEJ) and show
sensitivity to and cisplatin [65,66], while CBX4 is also required
for cellular resistance to IR [70]. Thus at least two pathways of
SUMOylation are essential components of DSB repair.
It is possible that specific SUMO isoforms have particular
roles at different portions of the response. Several reports
have suggested that earlier arriving components of the
DDR are modified by SUMO1 through PIAS4, and later arriv-
ing ones by SUMO2/3 through PIAS1 [31,65,71]. In one
study SUMO2/3 preceded SUMO1 [67], whereas others
observed simultaneous accumulation [66,68], and CBX4 loss
reduces both SUMO1 and SUMO2/3 accumulations at
DSBs [70].
The STUbl RNF4 plays multiple roles in DSB repair. Its
recruitment to sites of DSBs is dependent on its SIM motifs,
on SUMO2/3 and on PIAS1/4 SUMO ligases [68,72], and it
can be detected at laser lines within seconds of exposure, per-
sisting for several hours [68,69,72,73]. The presence of several
DNA repair factors improves RNF4 localization to breaks,
including SUMO targets MDC1, RNF8, 53BP1 and BRCA1
[68,72], whereas RNF4 depletion results in the persistence of
SUMO isoforms at laser line-induced damage [72]. RNF4,
and its yeast orthologues, interact directly with nucleosomes
and DNA and have a role in promoting ubiquitination of
H3 and telomere repair, but whether this activity also relates
to a role in global DSB repair is not known [74,75]. It is
possible RNF4 is primed for chromatin substrates in this way.
Intriguingly cycles of SUMO deconjugation appear critical
to the DDR. Expression of SUMO mutants that cannot be
deconjugated are disruptive to DSB repair [76]. Moreover,
knockdown of individual SENP enzymes, with the exception
of SENP3, each results in specific alterations in HR/NHEJ effi-
ciencies measured after a DSB of integrated reporters [76].
Some enzymes are likely to have dramatic impacts on SUMO
availability, either through directing SUMO maturation or by
allowing the release of free SUMO from conjugates. For
example loss of the Ulp2-related protease SENP6 dramatically
increases the amount of highmolecular weight SUMO2/3 con-
jugates and enlarges SUMO in promyelocytic leukaemia
protein (PML) nuclear bodies, suggesting it is responsible for
a large proportion of cellular SUMO2/3 editing [77]. Therequirement for SENP6 in assays of NHEJ and HR repair is res-
cued by supplying exogenous SUMO isoforms, suggesting
SUMO supply through SENP6 activity is required in the
DDR [76]. Other enzymes are likely to restrain SUMOylation
of a restricted subset of substrates. For example the requirement
inHR repair for theUlp2-related protease SENP7 cannot be res-
cued by increased SUMO supply and instead SENP7 has a role
in the chromatin relaxation required to allow DNA repair [76].
Non-redundancy and clear differences in localization and iso-
form specificity suggest further investigation will identify
specialist functions for SUMO proteases in DNA repair.4. SUMO repression of chromatin at DSBs
Chromatin context is critical forDNA repair outcome and chro-
matin-related ontologies are consistently highly ranked in
SUMO proteomes, with many of the most highly SUMOylated
proteins having roles in chromatin architecture. SUMOmodifi-
cation contributes to transcriptional repression in several
contexts [78–80], and SUMO is central to the maintenance of
heterochromatin [81,82]. Moreover, SUMO is found coupled
to multiple repressor complexes, in which SIM-bearing pro-
teins are also enriched [83]. SUMOylation induced by DNA
damage can influence patterns of gene expression through
specific factors such as HIC1 (Hypermethylated In Cancer 1)
[84–86]. Further, SUMO is part of the repressive chromatin
environment associated with the rapid and transient recruit-
ment of complexes to chromatin around DSBs. These include
NuRD and HDACs, the Suv39H1/KAP1/HP1 complex,
lysine demethylases and polycomb repressor complexes
(figure 4). Together these induce histone deacetylation and
increased H3K9me2/3 and increase nucleosome packing.
This initial repressive state is thought to prevent inappropriate
chromatin movement, to maintain the relationship between
DNA ends, and to contribute to local transcriptional silencing
(reviewed in [87]). However forDNA repair to proceed an open
chromatin structure is needed and overcoming SUMO-
mediated repression is part of the transition to a permissive
chromatin environment [88]. Examples of SUMO in chromatin
repression and release are described below.
SUMOylation of the polycomb repressor complex 1 (PRC1)
contributes to its recruitment to sites of DNA damage [70].
SUMOylation of the PRC1 Ub ligase component BMI1 at K88
in response to IR requires the PRC1 component and SUMO
ligase CBX4. BMI1, together with its partner RING1A/B, func-
tions as a Ub ligase, and ubiquitinate H2A at K119 both at
promoters and at sites of damage [89–91]. At damage sites it
contributes to local transcriptional repression [92–94] and
influences DDR Ub-signalling [90,95]. PRC1 recruitment had
been thought to be hierarchical though themethylation of chro-
matin via the PRC2 complex; however recent findings indicate
that PRC2 can be recruited by PRC1 modification of H2A-
K119-Ub [96,97]. Thus an initial recruitment of PRC1 promoted
by PARP activity and SUMO [70] could seed further spreading
of the complex at sites adjacent to DSBs.
Methylation on H3K4, H3K36 and H3K79 is generally
associated with active gene expression [98] with H3K4me3/2
residues marking the transcriptional start sites of actively
transcribed genes. Intriguingly the H3K4m2/3 demethylases
JARID1B and JARID1C are both SUMOylated in cells exposed
to MMS but with differing consequences. SUMOylation
of chromatin localized JARID1B is associated with its
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Figure 4. SUMOylated factors involved in DSB repair response. Proteins are grouped according to their enzyme class or functional complex. SUMO sites are from
Hendriks & Vertegaal 2016 [11], which compiled every SUMO site-mapping proteomic analysis published up to 2016. Sites are given a score depending on their
occurrence within different datasets, such that sites in multiple datasets are represented by larger circles. The functional dominance of these sites has not been
determined in most cases. Grey circles denote sites only found in cells that have been treated with stress; for details see reference [11]. The majority of studies were
performed using SUMO2, and individual SUMO isoforms are not shown. Proteins are shown to scale with only the longest isoform being used. Domain locations are
taken from UniProt. Abbreviations; BRCT (BRCA1 C-terminus), CC (coiled coil), CD (chromodomain), CSD (chromo-shadow domain), CUE (Cue ubiquitin binding), DBD
(DNA binding domain), FHA (forkhead-associated), GAR (Gly/Arg-rich), HRDC (helicase and RNaseD C-terminal), MBD (methyl binding domain), NET (N-terminal
extra-terminal domain), OLIGO (oligomerization domain), PHD (plant homeodomain), RING (really interesting new gene), SAP (SAF-A/B, Acinus and PIAS), SRA (SET-
and RING-associated domain), SPRY (SP1a and ryanodine receptor), SQ/TQ (region rich in SQ/TQ phosphorylation sites), UBL (ubiquitin-like), UDM (ubiquitin-depen-
dent recruitment module), UBZ (ubiquitin binding zinc finger), UDR (ubiquitin-dependent recruitment), ZnF (zinc finger).
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SUMOylation of the nucleoplasmic JARID1C coincides with
its chromatin recruitment and with global demethylation of
H2K4me3 and transcriptional downregulation. In addition
the H3K9me3 mark, increased on DNA damage [99] and
associated with transcriptional repression, may be associated
with SUMOylation of MBD1 and SETDB1 [41].
One of the most abundantly SUMOylated proteins in
human cells is the transcriptional repressor and heterochroma-
tin nucleator protein KAP1/TRIM28 ([11] and figure 4). KAP1
possesses auto-SUMO ligase activity within its PHD domain
and the majority of its SUMOylated lysines are found in the
C-terminal bromodomain (figure 4) [100]. SUMOylation of
KAP1 promotes interaction with the SIMs of the NuRD subunit
CHD3 and the methyltransferase SETDB1 [100]. This recruit-
ment promotes histone deacetylation and chromatinremodelling via the HDACs and CHD helicases contained
within the NuRD complex and H3K9 trimethylation by
SETDB1 which in turn promote gene silencing and chromatin
compaction. KAP1 interacts with HP1a, which binds to tri-
methylated H3K9 [101–103] so that the propagation of the
H3K9me3 along chromatin attracts additional HP1a proteins
which then recruit additional KAP1 molecules, allowing
spreading of heterochromatin, or a heterochromatin-like
state [104].
KAP1 localizes to sites of damage [105], and initially
spreads a repressive environment along tens of kilobases
[106]. Critically, the repressive influence of the SUMOylated
protein in this context is then attenuated by the DDR. This
occurs through activation of the Tip60 acetylase and activation
of ATM. ATM activity evicts the H3K9me2/3 methylase
SUV39H1, and releases the repressive HP1/KAP1 complex
rstb.royalsocietypublishing.org
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Ser824 adjacent to its bromodomain [107]. This phosphorylation
event also disrupts the SUMO-SIM interaction with CHD3 of
the NuRD complex. The subsequent release of CHD3, like
depletion of KAP1 itself [108], promotes chromatin relaxation
and allows DNA repair [107]. Heterochromatin contains
more repressive complexes and exhibits slower DSB repair
(reviewed in [109]) and the impact of ATM-mediated KAP1
phosphorylation on repair kinetics is most dramatically
observed in these more condensed regions [107,110,111].
Such a finely balancedmechanism suggests perturbation of
SUMOylation at chromatin might impact chromatin state and
subsequent DNA repair proficiency. Indeed cells depleted of
the chromatin-associated SUMO protease SENP7 fail to relax
chromatin following DNA damage [76]. Consequently, this
enzyme is required for resistance to DNA damaging agents
and to promote HR repair [76]. Like KAP1, SENP7 also inter-
acts with HP1a [76,112] and is enriched in heterochromatin
[112]. It acts to deSUMOylate KAP1 [76] and HP1a [112,113].
Chromatin association of the NuRD component CHD3
is increased in cells without SENP7 and importantly the
requirement for SENP7 in promoting chromatin relaxation,
HR-repair and resistance to IR is diminished if CHD3 is
depleted [76]. Thus it appears that SENP7 is needed to restrain
KAP1-CHD3 interaction by cleaving KAP1-SUMO conjugates.
Accessibility in euchromatin (transcribed genes) is severely
reducedwithout SENP7, butDNAdamagemarkers also persist
for longer in regions of heterochromatin [76], suggesting it too is
critical to DSB repair in heterochromatin. KAP1-SUMO is also
counteracted by the RNF4-VCP pathway. Both RNF4 and
VCP/p97 interact with pS824-KAP1-SUMO and RNF4 pro-
motes the degradation of SUMOylated KAP1 [114,115],
providing a further mechanism of chromatin derepression.
Thus the promotion of repressive chromatin by SUMO
interactions appears initially co-opted in the DDR, to pro-
mote the transient accumulation of repressive complexes
and to mediate DSB-associated transcriptional repression.
However it must then also be overcome to permit adequate
repair. Perhaps consistent with this notion is the finding
that SUMO conjugation sites in many proteins involved in
chromatin organization and modification are lost following
MMS treatment [41]. Thus widespread deSUMOylation or
SUMO-mediated degradation of chromatin-associated targets
appears a significant, and still largely unexplored, cellular
response to DNA damage.
5. SUMO in non-homologous end-joining
Throughout the cell cycle the most prominent form of DSB
repair is the error-prone pathway of non-homologous end-
joining (NHEJ). This process is reviewed extensively elsewhere
[116], but in simplified form the Ku70/80 heterodimer initiates
end binding, encircling theDNA, and recruits theDNA-PK cat-
alytic subunit. Complex ends are then trimmed to blunt ends
by proteins such as Artemis or PNKP and the XRCC4/XLF/
PAXX complex stabilizes DNA ligase IV which joins the
DNA ends together. Several NHEJ factors are SUMOmodified
in mammalian cells (figure 4) but any influence on function
is understood for just a few factors. XRCC4 SUMOylation is
linked to its nuclear localization [117]. Cells expressing a
form of XRCC4 with an arginine at the K210 SUMOylation
site show a cytoplasmic localization coupled with sensitivity
to IR and poor V(D)J recombination. Importantly fusingSUMO to the C-terminus restores normal localization of
XRCC4 and radio-resistance [117]. In yeast, SUMOylation
enhances theDNAassociation ofKu70 [118] and inmammalian
cells increased expression of SUMO conjugation components
causes Ku70 stabilization, although this effect may be indirect
[119].Nevertheless, a role for SUMO interactions inmammalian
NHEJ is suspected as expression of SIM-peptides can block
NHEJ and increase cellular radio-sensitivity [120]. These pep-
tides immunoprecipitate SUMO-Ku70, suggesting an as yet
unidentified interaction with modified Ku70may be significant
in the repair process [120]. Perhaps consistent with these obser-
vations is the finding that loss ofRNF4,whichbears tandemSIM
motifs, reduces NHEJ repair outcomes through an as yet
unknown pathway [72,115]. Ku70/Ku80 encircle DNA ends
[121], where they prevent extensive resection, and promote
DNA-PKcs (DNA-dependent protein kinase, catalytic subunit)
recruitment. However after DNA ligation Ku70/80 rings
remain locked on the DNA and are deleterious unless removed
[122]. RNF8,RNF138andSCFubiquitin ligaseshavebeen impli-
cated in the disengagement of Ku80 [123–125] and VCP/p97
and its ubiquitin binding receptors have been shown to be
required for extraction of both Ku70 and Ku80 from damaged
DNA [126]. As each Ku subunit independently encircles the
DNA [121], an attractive, but as yet untested,model for removal
of Ku70 is its SUMO-mediated Ub targeting and subsequent
extraction.
6. SUMO in DNA damage response signalling
DNA double-stranded breaks (DSBs) are also recognized by a
signalling complex composed of NBS1, RAD50 and MRE11A
(MRN).MRN helps to recruit the kinase ATMwhich phosphor-
ylates multiple components of the DSB pathway, including the
histone variant H2AX at Ser139 [127]. MDC1 is recruited to
phosphorylated H2AX through its BRCT domain and is critical
to subsequent DSB signalling [128–131]. It begins a Ub signal-
ling cascade involving the E3 Ub ligases RNF8/RNF168, Ub
conjugating enzyme, UBE2N/UbcH13, and two factors that
promote RNF8 interactions, HERC2 and JMJD1C (reviewed
elsewhere [132]). SUMO-dependent recruitment of the PRC1
complex brings the BMI1 : RING1A/B Ub ligase [70] which
then contributes to activation of the Ub signalling pathway
[90,92,95,133] (although its recruitment has been disputed
[134]). This Ub cascade results in the recruitment of the
BRCA1-A complex and 53BP1.
MDC1,HERC2 andRNF168 are SUMOmodified by PIAS4
following DNA damage [31,40,43,68,71]. The demethylase
JMJD1C which binds to RNF8 and MDC1 [135], the Ub E2
enzyme UBE2N/UbcH13 which cooperates with RNF8 and
RNF168, and RNF8 itself are also SUMOylated at multiple
sites, although it is not known which ligases are responsible,
nor what function their SUMOylation may have [15,31].
These proteins could be seen as a protein group, co-located
in time and space and therefore an example of the SUMO
spray model [53]. However, in a departure from that model,
SUMOylation of at least some individual components has
distinct functional outcomes.
MDC1 SUMOylation drives RNF4 interaction after
exposure to IR [68,71]. A single lysine, K1840, appears to be
the major site of MDC1 SUMOylation [71] and in cells without
RNF4 or PIAS4, or expressing K1840R-MDC1, the protein
shows slowed clearance from sites of damage [71,72]. More-
over, K1840R-MDC1 fails to rescue radio-sensitivity of
rstb.royalsocietypublishing.org
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SUMOylated MDC1 is antagonized by the DUB ATXN3
which is recruited to DSBs in a SUMO-dependent manner.
ATXN3 therefore acts as a brake on MDC1 turnover at DSB
which is essential for proper downstream signalling and
HR/NHEJ repair efficiencies [73]. The consequences of
prolonged association of MDC1 at damage sites is reduced
HR repair, potentially through an increased 53BP1 association
[71]. In contrast SUMOylation of HERC2 relates to the pro-
motion of an inter-molecular structural interaction, in which
the ZZ-type zinc finger in HERC2 is suggested to mediate
interaction with SUMO-modified HERC2, resulting in either
a conformational change or novel interaction that regulates
its ability to interact with RNF8 [31]. In yet another functional
outcome the SUMO E3 ligase PIAS4 supports RNF168 protein
stability and promotes its transcription [31].
The RNF8/RNF168 Ub cascade results in the recruitment
of the BRCA1-A complex to sites of DSBs through the K63-Ub
linkage and SUMO sensor RAP80, a component of the
BRCA1-Acomplex [136–142]. Inaddition toadualUb-interacting
motif (UIM) [139,143] RAP80 carries a SUMO-interacting
motif (SIM). These bind Ub-SUMO hybrid chains with high
affinity [143]. Both the SIM and UIM domains are required
for efficient recruitment of RAP80 to DSBs immediately
after damage and confer cellular resistance to ionizing radi-
ation [67]. The K63-Ub-SUMO bound by RAP80 is reported
to be provided by RNF4 [58], which is capable of generating
K63-linked Ub chains [144]. Further work is needed to estab-
lish the degree to which SUMO binding mediates the
interaction of RAP80 with the K63-Ub chains generated by
RNF8/168, which are also required for RAP80 recruitment
[145], and whether SUMO-Ub hybrids occur on any specific
substrate(s).
BRCA1 and 53BP1 recruited to sites of DSBs are cell cycle
specific gate-keepers to the critical HR step of DNA resection,
where the 50 ends of the DSB are subject to nuclease proces-
sing. 53BP1 acts to restrain resection in G1, and BRCA1 acts
to promote it in late S and G2 [146–149]. BRCA1 is SUMO-
ylated in response to IR and other DNA damaging agents
[41,65,66,68] through PIAS1/4 SUMO ligases at several sites
including at its N-terminus (figure 4). SUMOylation is associ-
ated with increased BRCA1 : BARD1 Ub ligase activity
in vitro [66] although whether this increased activity relates
to SIMs in Ub conjugating enzymes, or is structurally related
to a similar potentiation of ligase activity induced by auto-
ubiquitination [1,150], is not clear. The functional role of the
Ub ligase activity of BRCA1 in DDR has for many years
been controversial, but recent reports suggests it promotes
Ub modification of the extreme C-terminus of H2A [151],
which in turn encourages the recruitment and activation of
the remodeller SMARCAD1 resulting in increased long-
range DNA resection [95,152]. Whether SUMOylation of
BRCA1 : BARD1 also potentiates resection remains to be
seen and the relationship of BRCA1 SUMOylation with the
different BRCA1 complexes, of which only one is expected
to promote resection, is currently unknown. SUMOylated
BRCA1 is a substrate for RNF4 [69], suggesting its clearance
also requires SUMOylation.
53BP1 is a reproducible substrate of SUMO modification
on DNA damage [65,68] with several sites mapped
(figure 4). Currently there are no reports of mutation of the
sites, or SUMO fusion, or any impact of RNF4 or VCP/p97
directly on 53BP1. Loss of PIAS4 reduces 53BP1 localization[65], but this may be an indirect effect through the ligase’s
impact onRNF168 [153]. 53BP1 acts to promoteNHEJ and inhi-
bit resection of DNA ends through its effector proteins, PTIP,
RIF1, Artemis and Rev7. These have not yet been identified
as SUMOylated and the role, if any, of 53BP1 SUMOylation
awaits investigation.7. SUMO in resection and recombination
In late S-phase and G2 stages of the cell cycle error-free DNA
repair is possible using the sister chromatid as a template for
HR repair. The 50 resection of the double-stranded DNA to pro-
duce 30 overhangs, required for HR, employs the enzymatic
activities of Mre11-CtIP, EXO1 and BLM/DNA2 (reviewed
extensively elsewhere [154]). The single-stranded DNA
(ssDNA) produced is first bound by RPA, and then exchanged
bytheactionofBRCA2forRAD51.Recentdata suggest anemer-
ging role for SUMOin thisprocess, asmostproteinswith adirect
role in resection are SUMOmodified. Components of the MRN
complex, including MRE11, are SUMOylated following infec-
tion with adenovirus 5 (Ad5), which triggers a DSB response
as the ends of the viral genome mimic host cell DSBs [155,156]
andmultipleSUMOsiteshavebeen identifiedon theMRNcom-
ponents from SUMO site-mapping screens (figure 4). BLM is
SUMO modified in response to IR and replication stress
[69,157] and after replication fork collapse SUMO-modified
BLM is implicated in promoting RAD51 foci formation
[157,158]. EXO1 is SUMOylated by PIAS4 which reduces its
stability, whereas loss of the SUMOylation sites of EXO1
improves the protein’s stability [159]. In addition the ssDNA
binding protein subunit RPA70/RPA1 itself bears a critical
SUMO-modification site which is required for subsequent
RAD51 accumulation [160]. Moreover, both RPA1 and EXO1
are bound by the SUMO protease SENP6 which is reported to
promote their hypoSUMOylation [159,160].
These observations suggest that the resection process is
SUMO rich, and might be ‘read’ by specific mediators. Intri-
guingly both the scaffold protein for many structure-specific
endonucleases, SLX4, and RAD51 carry SIM motifs critical to
their function [161,162]. SLX4 localization to laser-induced
damage requires its SIMs and the SUMO pathway [162].
The SLX SIMs are required for normal cell resistance to
camptothecin, suggesting a role related to DSBs associated
with replication-associated DNA damage. SUMO binding
increases SLX4 interaction with MRN and RPA [162] and
although SLX4 binds to SUMOylated forms of these proteins
recruitment is also thought to be promoted by other SUMO
targets, to account for its SUMO-dependent recruitment.
Similarly SUMO concentration may promote the ability
of RAD51 to ‘read’ resection. A direct interaction between
RAD51 and SUMO was first established by yeast two hybrid
interaction [163]. RAD51 contains a conserved C-terminal
SIM (VAVV 261–264) and mutation of this sequence abrogates
RAD51 accumulation at laser lines and reduces HR-mediated
repair [164]. The interaction partner(s) of this SIM is not
known but candidates in the resection processes are appealing.
The potential for SUMO-targeting Ub ligases to regulate
aspects of resection and recombination is therefore significant
and indeed several studies agree that loss of the STUbl RNF4
is associated with reduced RAD51 foci formation and poor
HR outcome [68,71,72]. However while two studies suggest
the defect in cells without RNF4 is at the level of reduced
rstb.royalsocietypublishing.org
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turn 53BP1 [71], another suggests RNF4-mediated turnover of
SUMO-RPA1 determines RPA residency at already resected
DNA, resulting in reduced RAD51 loading [72]. Taking resec-
tion and recombination together it would appear that SUMO
plays several, sometimes counteracting, roles, promoting
protein stability and interaction but also clearance, depending
on the substrate. It is perhaps not surprising that different
studies locate different DDR pressure points that the RNF4
‘wrecking ball’ is required to transit. Indeed it seems likely
that there are yet further roles for RNF4 in this pathway to be
discovered. il.Trans.R.Soc.B
372:201602818. Conclusion and questions
Insight into how SUMO modification coordinates the funda-
mental process of DNA double-strand break (DSB) repair is
emerging. Indeed this may contribute to further understand-
ing of the established role SUMOylation has in ageing and
senescence [165], and neurological disorders [166]. The role
of SUMO in transcriptional repression and maintenance of
heterochromatin appears co-opted in the acute response to
damage but is then overcome to open chromatin structure.
Given the differing chromatin environments that DSBs
arise in, the possibility that SUMO influences different repair
outcomes in differing contexts appears likely.
The catalogue of SUMOylated proteins in the DDR is
expanding [11] but a striking conclusion of surveying examples
of SUMO modification in the mammalian DDR is the varied
ways in which SUMO impacts protein function, even when
an apparent protein group is modified. The DDR uses all
variants of SUMO target fate to drive interactions and tran-
sitions that permit the response to proceed. Our current
overview of SUMO function in the DDR points to several
points of precision and instances of opposing functional out-
come of SUMO modification of similarly located proteins.
Thus an indiscriminate SUMO ‘spray’ and subsequent protein
group modification directing the accumulation of SUMO :
SIM-associated complexes prevalent in the yeast DDR [26]
would appear to be a less dominant mechanism of SUMO
function in the mammalian response.
The steady-state of target-protein SUMO modification
is a consequence of conjugation/deconjugation and target-protein stability, and thus the majority of our cataloguing of
SUMOylated targets perhaps represents sites less amenable
to isopeptidase or STUbL access. While work developing our
understanding of SUMO conjugation is growing, an under-
studied area is SUMO protease regulation. The constitutively
high activity of these enzymes means that regulation at the
level of modification removal may be as significant to target
proteins and protein groups as the conjugation itself. Since
SUMO proteases are potential targets for small molecules
[167–169], with potential utility in several human disease
states, there is a need to further establish their roles. Future
SUMO site-mapping experiments, identifying SUMO targets
in cells with removal or inhibition of specific SUMO proteases
and STUbls, will greatly improve our understanding of the
dynamics of SUMOylation in different sub-nuclear-
compartments and after particular stimuli, such as DSBs.
SUMOylation exhibits considerable cross-talk between
PTM pathways, as described herein with Ub modification,
but also with phosphorylation [15,16] and thus investigation
of SUMO and SUMO targets is necessary to gain an integrated
view of how DSB repair is orchestrated. This point is conspic-
uous when thinking about the dense signalling environment
of chromatin. For example H2AX is also SUMOylated by
PIAS4 in response to various DNA damaging agents [170]
with major conjugation sites at K128 and K135 [15,37].
SUMO is a bulky adduct relative to histones and nucleosome
structurewith potential to impact packing or affect interactions
with nearby phosphorylated S139 or Ub-modified K119/120.
Finally, as SUMOsitemapping reaches saturation a key goal
for the future is to establish the mechanisms and circuits of
SUMOylation in the DDR and their integration into our wider
understanding of the response. By these means, how SUMO
dynamics contribute to maintaining a stable genome, and how
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